Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
J Domínguez-Ortega, J A Luna-Porta, J M Olaguibel, P Barranco, E Arismendi, B Barroso, D Betancor, I Bobolea, M L Caballero, B Cárdaba, M J Cruz, E Curto, F J González-Barcala, I Losantos-García, C Martínez-Rivera, P Mendez-Brea, J Mullol, X Muñoz, C Picado, V Plaza, V Del Pozo, M J Rial, J Sastre, L Soto, A Valero, M Valverde-Monge, S Quirce, J Domínguez-Ortega, J A Luna-Porta, J M Olaguibel, P Barranco, E Arismendi, B Barroso, D Betancor, I Bobolea, M L Caballero, B Cárdaba, M J Cruz, E Curto, F J González-Barcala, I Losantos-García, C Martínez-Rivera, P Mendez-Brea, J Mullol, X Muñoz, C Picado, V Plaza, V Del Pozo, M J Rial, J Sastre, L Soto, A Valero, M Valverde-Monge, S Quirce
Abstract
Background and objective: Comorbidities can influence asthma control and promote asthma exacerbations (AEs). However, the impact of multimorbidity in AEs, assessed based on long-term follow-up of patients with asthma of different degrees of severity, has received little attention in real-life conditions. To describe the epidemiological and clinical characteristics and predictors of AEs in patients who had presented at least 1 AE in the previous year in the MEchanism of Genesis and Evolution of Asthma (MEGA) cohort.
Methods: The work-up included a detailed clinical examination, pulmonary function testing, fractional exhaled nitric oxide (FeNO), blood counts, induced sputum, skin prick-tests, asthma questionnaires, and assessment of multimorbidity. The number of moderate-severe AEs in the preceding year was registered for each patient.
Results: The study population comprised 486 patients with asthma (23.7% mild, 35% moderate, 41.3% severe). Disease remained uncontrolled in 41.9%, and 47.3% presented ≥1 moderate-severe AE, with a mean (SD) annual exacerbation rate of 0.47 (0.91) vs 2.11 (2.82) in mild and severe asthma, respectively. Comorbidity was detected in 56.4% (66.6% among those with severe asthma). Bronchiectasis, chronic rhinosinusitis with nasal polyps, atopy, psychiatric illnesses, hyperlipidemia, and hypertension were significantly associated with AEs. No associations were found for FeNO, blood eosinophils, or total serum IgE. Sputum eosinophilia and a high-T2 inflammatory pattern were significantly associated with AEs. Multivariable regression analysis showed a significant association with asthma severity, uncontrolled disease, and low prebronchodilator FEV1/FVC.
Conclusion: Our study revealed a high frequency of AE in the MEGA cohort. This was strongly associated with multimorbidity, asthma severity, poor asthma control, airflow obstruction, higher sputum eosinophils, and a very high-T2 inflammatory pattern.
Keywords: Asthma; Asthma control; Exacerbations; MEGA cohort; Multimorbidity.
Source: PubMed